AMETEK, Inc. vs DANAHER CORPORATION, two Scientific Instruments stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where AME and DHR diverge most: on revenue growth, AME reads +12.6% and DHR reads +4.5%; on debt / equity, AME reads 0.18 and DHR reads 0.50. The rest of the comparable metrics sit closer together. What AME's price implies is a bet that sits within the historical range (whole-company basis). What DHR's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | AME | DHR |
|---|---|---|
| Price | $248.36 | $219.80 |
| Market cap | $57.1B | $155.5B |
| Sector | Scientific Instruments | Scientific Instruments |
| Stage | Growth | Mature |
| Implied growth (priced in) | — | +23.2% |
| P/E | 36.3 | 39.0 |
| P/B | 5.07 | 2.96 |
| P/S | 7.26 | 6.19 |
| EV/EBITDA | 23.9 | 23.2 |
| Revenue growth | +12.6% | +4.5% |
| Gross margin | — | 57.6% |
| Operating margin | 25.8% | 18.0% |
| Net margin | 20.0% | 15.9% |
| Return on equity | 14.0% | 7.6% |
| Return on assets | 9.5% | 4.3% |
| Return on invested capital | 12.7% | 5.2% |
| FCF yield | 3.2% | 3.5% |
| Dividend yield | 0.2% | — |
| Debt / equity | 0.18 | 0.50 |
| Current ratio | 1.21 | 1.65 |
| Altman Z (solvency) | 7.71 | 7.11 |
| Piotroski F (quality) | 8 / 9 | 5 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.